Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Felley

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
European Radiology|May 24, 2003
Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of "sign-by-sign" correlationSabine Schmidt, Domenico Lepori, Jean-Yves Meuwly, et al.
Journal of Crohn'S & Colitis|May 14, 2013
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panelValerie Pittet, Florian Froehlich, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
AIDS (London, England)|July 9, 2004
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control studyChristian Felley, Michael A Morris, Ambroise Wonkam, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT IIPascal Juillerat, John-Paul Vader, Christian Felley, et al.
Scandinavian Journal of Gastroenterology|July 27, 2010
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohortPascal Juillerat, Valérie Pittet, Christian Mottet, et al.
Inflammatory Bowel Diseases|December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS surveyAlain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT IIPierre Michetti, Marc Stelle, Pascal Juillerat, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriatenessPascal Juillerat, Valérie Pittet, John-Paul Vader, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
European Radiology|May 24, 2003
Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of "sign-by-sign" correlationSabine Schmidt, Domenico Lepori, Jean-Yves Meuwly, et al.
Journal of Crohn'S & Colitis|May 14, 2013
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panelValerie Pittet, Florian Froehlich, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
AIDS (London, England)|July 9, 2004
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control studyChristian Felley, Michael A Morris, Ambroise Wonkam, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT IIPascal Juillerat, John-Paul Vader, Christian Felley, et al.
Scandinavian Journal of Gastroenterology|July 27, 2010
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohortPascal Juillerat, Valérie Pittet, Christian Mottet, et al.
Inflammatory Bowel Diseases|December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS surveyAlain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT IIPierre Michetti, Marc Stelle, Pascal Juillerat, et al.
European Journal of Gastroenterology & Hepatology|October 23, 2010
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriatenessPascal Juillerat, Valérie Pittet, John-Paul Vader, et al.
Pageof 6